Mentor assets increased to $6.6 million in June 2011 from $1.4 million in June 2010. The majority of the increase occurred in May 2011 upon the acquisition of an interest in a cancer neutron therapy company. The cancer related interest is carried at cost irrespective of financial and technical milestone progress of the neutron therapy program.